Bone Marrow Transplant Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Mesenchymal Stem Cell Infusion for COVID-19 Infection
Condition: COVID-19 Interventions: Drug: Mesenchymal stem cells; Other: Placebo Sponsor: Armed Forces Bone Marrow Transplant Center, Rawalpindi, Pakistan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2020 Category: Research Source Type: clinical trials

Phase 2 Trial of CD19 Redirected Autologous T Cells
Conditions: Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL; Infants With Very High Risk KMT2A B-ALL; Patients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation Intervention: Biological: Murine CART19 Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2020 Category: Research Source Type: clinical trials

Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients
Condition: Hematopoietic Stem Cell Transplant Interventions: Drug: 2'-fucosyllactose; Other: Placebo (2g oral glucose) Sponsor: Children's Hospital Medical Center, Cincinnati Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials